https://feeds.newsfilecorp.com/company/12855 Latest news from Solvonis Therapeutics plc, as distributed by TMX Newsfile. en CopyRight (c) 2026, Newsfile Corp. All Rights Reserved. office@newsfilecorp.com (Newsfile Corp.) office@newsfilecorp.com (Newsfile Corp.) Thu, 05 Nov 2026 09:24:56 -0500 https://images.newsfilecorp.com/logos/12855.jpg https://feeds.newsfilecorp.com/company/12855 https://www.newsfilecorp.com/release/322692/Solvonis-Therapeutics-plc-Announces-US-Patent-Office-Allows-Ketamine-Patent-Across-All-Behavioural-Addictions Behavioural addictions estimated to affect over 48 million Americans¹THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 AS IT FORMS PART OF DOMESTIC LAW IN THE UNITED KINGDOM BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION WILL BE CONSIDERED TO BE IN THE PUBLIC DOMAIN.London, United Kingdom--(Newsfile Corp. - November 5, 2026) -...<img src="https://api.newsfilecorp.com/newsinfo/322692/156" id="156" width="2" height="2" style="width: 1px; height: 1px;border: 0px solid;" /> Thu, 05 Nov 2026 09:21:00 -0500 en https://www.newsfilecorp.com/release/322692